Orchid Pharma Limited Share Price Bombay S.E.
Equities
524372
INE191A01019
Pharmaceuticals
Sales 2024 | 819.37Cr 9.81Cr | Sales 2025 * | 1.03TCr 12Cr | Capitalization | 5.37TCr 64Cr |
---|---|---|---|---|---|
Net income 2024 | 92Cr 1.1Cr | Net income 2025 * | 148.6Cr 1.78Cr | EV / Sales 2024 | 6.31 x |
Net cash position 2024 | 132.09Cr 1.58Cr | Net cash position 2025 * | 164.8Cr 1.97Cr | EV / Sales 2025 * | 5.06 x |
P/E ratio 2024 |
72.1
x | P/E ratio 2025 * |
35.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31/20/31 |
Director of Finance/CFO | - | 29/20/29 | |
Kapil Dayya
CMP | Compliance Officer | - | 16/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 31/20/31 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 31/20/31 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31/20/31 |
1st Jan change | Capi. | |
---|---|---|
+41.96% | 63TCr | |
-7.15% | 35TCr | |
+18.77% | 33TCr | |
+8.79% | 30TCr | |
+18.02% | 25TCr | |
+1.27% | 22TCr | |
+11.95% | 22TCr | |
+3.68% | 16TCr | |
-4.38% | 16TCr |